Free Press Release

FaceBook Page Twitter Feed
You are here: Home > Exclusive News > Health Point Inc. IPO Price Re-Valued Upwards 50% to $12

Health Point Inc. IPO Price Re-Valued Upwards 50% to $12

Posted Nov 26, 2014 by reginaldanderson
Health Point Inc. continues to receive rapidly growing interest through early subscriptions from potential investors for its early 2015 initial public offering, pointing to a potential sellout.

FOR IMMEDIATE RELEASE (Press Release) Nov 26, 2014 -- Industry experts agree that with additional funding from the public offering, Health Point Inc. will be very well positioned to expand its operations and greatly increase the companies' market value. Research reputation is is key to increased market share, and is confirmed by the global clinical research communities frequent lauding of Health Point Inc's important stem cell research contributions.

As an important and growing field, stem cell research and treatment is considered the most likely path to expanding treatments for the worlds most common medical challenges. Health Point Inc., through its state of the art research facilities and strategic partnerships, is well positioned to be a global leader in this field.

Health Point Inc. (HPI) is a privately-owned company specializing in the development, manufacture and supply of stem cells for basic research and therapeutic development for the treatment of various diseases and conditions. The company utilizes what it calls Creative (stem cell-based) technology and other developed proprietary methods in the field of regenerative medicine that would enable drug discovery and life-changing therapies. More information can be found at

Health Point Inc. is committed to deliver safe, effective and affordable stem cell therapies in a bench-to-bed approach, by nurturing cutting-edge research and clinical applications and by matching customer satisfaction in attaining the rejuvenating hope. Health Point Inc. strives to maintain scientific and ethical practices through a Quality Management System in accordance with accepted national and international norms. Health Point Inc. will accomplish this through dedicated efforts of its team to continually monitor and improve the effectiveness of the Quality Management System to excel and innovate thereby reflecting that we are truly pro-Life.

The information contained in this release is provided on an errors and omissions excepted basis. No statements contained within are to be construed as an offer for sale of share capital or any other offer contrary to securities law. Information is current at time of publishing. Health Point Inc. cannot be held responsible for out of date or changing information. It is the responsibility of the reader to seek out up to date company information at and other sources before making any material decisions.
-- EOF ---
Contact Email :
Issued By : Reginald Anderson
Phone : 85281930750
Business Address : 15/F Millennium City 5 (APM)
418 Kwun Tong Rd Central, Hong Kong
Country : China
Categories : Business
Tags : health, Stem Cells, Research, Manufacture, Supply, Investment
Last Updated : Nov 26, 2014

New Press News

blog comments powered by Disqus
Popular TagsMore